{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:25:29Z","timestamp":1787221529222,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Takeda (China) International Trading Company"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"DOI":"10.1007\/s00383-026-06474-8","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:51:10Z","timestamp":1787219470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of teduglutide in children with short bowel syndrome: a narrative review"],"prefix":"10.1007","volume":"42","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"6474_CR1","doi-asserted-by":"publisher","first-page":"8S","DOI":"10.1177\/0148607114520994","volume":"38","author":"PB Jeppesen","year":"2014","unstructured":"Jeppesen PB (2014) Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure. J Parenter Enter Nutr 38:8S\u201313S. https:\/\/doi.org\/10.1177\/0148607114520994","journal-title":"J Parenter Enter Nutr"},{"key":"6474_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40265-017-0703-7","volume":"77","author":"ES Kim","year":"2017","unstructured":"Kim ES, Keam SJ (2017) Teduglutide: a review in short bowel syndrome. Drugs 77:345\u2013352. https:\/\/doi.org\/10.1007\/s40265-017-0703-7","journal-title":"Drugs"},{"key":"6474_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cgh.2005.10.002","volume":"4","author":"SJ O'Keefe","year":"2006","unstructured":"O\u2019Keefe SJ et al (2006) Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 4:6\u201310. https:\/\/doi.org\/10.1016\/j.cgh.2005.10.002","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6474_CR4","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2147\/PPA.S443026","volume":"18","author":"Y Chen","year":"2024","unstructured":"Chen Y et al (2024) A systematic review of quality of life in patients with short bowel syndrome and their caregivers. Patient Prefer Adherence 18:1217\u20131230. https:\/\/doi.org\/10.2147\/PPA.S443026","journal-title":"Patient Prefer Adherence"},{"key":"6474_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5223\/pghn.2019.22.4.303","volume":"22","author":"O Goulet","year":"2019","unstructured":"Goulet O et al (2019) Short bowel syndrome as the leading cause of intestinal failure in early life: some insights into the management. Pediatr Gastroenterol Hepatol Nutr 22:303\u2013329. https:\/\/doi.org\/10.5223\/pghn.2019.22.4.303","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"6474_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/0148607113512678","volume":"38","author":"DG Kelly","year":"2014","unstructured":"Kelly DG, Tappenden KA, Winkler MF (2014) Short bowel syndrome: highlights of patient management, quality of life, and survival. J Parenter Enter Nutr 38:427\u2013437. https:\/\/doi.org\/10.1177\/0148607113512678","journal-title":"J Parenter Enter Nutr"},{"key":"6474_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jpen.1958","volume":"45","author":"CB Nordsten","year":"2021","unstructured":"Nordsten CB et al (2021) High parenteral support volume is associated with reduced quality of life determined by the short-bowel syndrome quality of life scale in nonmalignant intestinal failure patients. JPEN J Parenter Enteral Nutr 45:926\u2013932. https:\/\/doi.org\/10.1002\/jpen.1958","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"6474_CR8","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.clinthera.2018.09.009","volume":"40","author":"R Ballinger","year":"2018","unstructured":"Ballinger R et al (2018) Measurement of utilities associated with parenteral support requirement in patients with short bowel syndrome and intestinal failure. Clin Ther 40:1878-1893e.e1. https:\/\/doi.org\/10.1016\/j.clinthera.2018.09.009","journal-title":"Clin Ther"},{"key":"6474_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1053\/j.sempedsurg.2009.11.010","volume":"19","author":"ME McMellen","year":"2010","unstructured":"McMellen ME, Wakeman D, Longshore SW (2010) Growth factors: possible roles for clinical management of the short bowel syndrome. Semin Pediatr Surg 19:35\u201343. https:\/\/doi.org\/10.1053\/j.sempedsurg.2009.11.010","journal-title":"Semin Pediatr Surg"},{"key":"6474_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1389203043486946","volume":"5","author":"J Thulesen","year":"2004","unstructured":"Thulesen J (2004) Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator. Curr Protein Pept Sci 5:51\u201365. https:\/\/doi.org\/10.2174\/1389203043486946","journal-title":"Curr Protein Pept Sci"},{"issue":"3","key":"6474_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/1756283X11436318","volume":"5","author":"PB Jeppesen","year":"2012","unstructured":"Jeppesen PB (2012) Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Th Adv Gastroenterol 5(3):159\u2013171. https:\/\/doi.org\/10.1177\/1756283X11436318","journal-title":"Th Adv Gastroenterol"},{"key":"6474_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpeds.2016.10.027","volume":"181","author":"BA Carter","year":"2017","unstructured":"Carter BA et al (2017) Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome. J Pediatr 181:102-111.e5. https:\/\/doi.org\/10.1016\/j.jpeds.2016.10.027","journal-title":"J Pediatr"},{"key":"6474_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/jpen.1690","volume":"44","author":"SA Kocoshis","year":"2020","unstructured":"Kocoshis SA et al (2020) Safety and efficacy of teduglutide in pediatric patients with intestinal failure due to short bowel syndrome: a 24-week, phase III study. JPEN J Parenter Enteral Nutr 44:621\u2013631. https:\/\/doi.org\/10.1002\/jpen.1690","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"6474_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.866518","volume":"9","author":"F Gigola","year":"2022","unstructured":"Gigola F et al (2022) Use of teduglutide in children with intestinal failure: a systematic review. Front Nutr 9:866518. https:\/\/doi.org\/10.3389\/fnut.2022.866518","journal-title":"Front Nutr"},{"key":"6474_CR15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/MPG.0000000000003922","volume":"77","author":"A Fifi","year":"2023","unstructured":"Fifi A et al (2023) Effects of teduglutide on diarrhea in pediatric patients with short bowel syndrome-associated intestinal failure. J Pediatr Gastroenterol Nutr 77:666\u2013671. https:\/\/doi.org\/10.1097\/MPG.0000000000003922","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6474_CR16","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/jpen.2061","volume":"45","author":"S Hill","year":"2021","unstructured":"Hill S et al (2021) Safety findings in pediatric patients during long-term treatment with teduglutide for short-bowel syndrome-associated intestinal failure: pooled analysis of 4 clinical studies. JPEN J Parenter Enteral Nutr 45:1456\u201365. https:\/\/doi.org\/10.1002\/jpen.2061","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"6474_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MPG.0000000000003541","volume":"75","author":"A Guz-Mark","year":"2022","unstructured":"Guz-Mark A et al (2022) The variable response to teduglutide in pediatric short bowel syndrome: a single country real-life experience. J Pediatr Gastroenterol Nutr 75:293\u20138. https:\/\/doi.org\/10.1097\/MPG.0000000000003541","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6474_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/MPG.0000000000003867","volume":"77","author":"M Chiba","year":"2023","unstructured":"Chiba M, Masumoto K, Kaji T, Matsuura T, Morii M, Fagbemi A et al (2023) Efficacy and safety of teduglutide in infants and children with short bowel syndrome dependent on parenteral support. J Pediatr Gastroenterol Nutr 77:339\u201346. https:\/\/doi.org\/10.1097\/MPG.0000000000003867","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6474_CR19","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ajcnut.2023.02.019","volume":"117","author":"C Lambe","year":"2023","unstructured":"Lambe C, Talbotec C, Kapel N, Barbot-Trystram L, Brabant S, Nader EA et al (2023) Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome. Am J Clin Nutr 117:1152\u20131163. https:\/\/doi.org\/10.1016\/j.ajcnut.2023.02.019","journal-title":"Am J Clin Nutr"},{"key":"6474_CR20","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/MPG.0000000000002899","volume":"71","author":"E Ramos Boluda","year":"2020","unstructured":"Ramos Boluda E, Redecillas Ferreiro S, Manrique Moral O, Garcia Romero R, Irastorza Terradillos I, Nunez Ramos R et al (2020) Experience with teduglutide in pediatric short bowel syndrome: first real-life data. J Pediatr Gastroenterol Nutr 71:734\u20139. https:\/\/doi.org\/10.1097\/MPG.0000000000002899","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6474_CR21","first-page":"11","volume":"69","author":"D Mercer","year":"2019","unstructured":"Mercer D, Carter B, Hill S, Horslen S, Kaufman S, Kocoshis S et al (2019) A prospective, open-label, long-term safety and efficacy study of teduglutide in pediatric patients with short bowel syndrome-associated intestinal failure: 6-month interim analysis. J Pediatr Gastroenterol Nutr 69:11\u201314","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6474_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000576432.44757.42","volume":"103","author":"MI Mart\u00ednez","year":"2019","unstructured":"Mart\u00ednez MI, Rumbo C, Fern\u00e1ndez A, Gondolesi GE (2019) Teduglutide: intestinal rehabilitation in children, our initial experience. Transplantation 103:PS162. https:\/\/doi.org\/10.1097\/01.tp.0000576432.44757.42","journal-title":"Transplantation"},{"key":"6474_CR23","unstructured":"Carter BA, Raphael B, Cohran V, Hill S, Matthews C et al (2022) Pooled analysis of open-label, long-term pediatric extension studies: Safety and efficacy of teduglutide in patients with short bowel syndrome associated intestinal failure. Presented at the 50th NASPGHAN Annual Meeting, October 12\u201315, 2022, Florida, USA"},{"key":"6474_CR24","unstructured":"Carter BA, Cohran V, Hill S, Horslen S, Kaufman SS et al (2019) Long-term retrospective follow-up of pediatric patients with short bowel syndrome\u2013associated intestinal failure (SBS\u2013IF) who completed 12 weeks of treatment in TED-C13-003. Poster presented at the Annual Meeting of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition; October 17\u201319, 2019; Chicago, IL, USA"},{"key":"6474_CR25","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1097\/MPG.0000000000003177","volume":"72","author":"F Ribeiro-Mour\u00e3o","year":"2021","unstructured":"Ribeiro-Mour\u00e3o F, de Braganca RL, Nogueira M, Guerra P, Espinheira C et al (2021) Short-term results of teduglutide therapy in children with short bowel syndrome. J Pediatr Gastroenterol Nutr 72:1300. https:\/\/doi.org\/10.1097\/MPG.0000000000003177","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6474_CR26","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/MPG.0000000000003177","volume":"72","author":"V Busoni","year":"2021","unstructured":"Busoni V, Izquierdo C, Frangi F, Lobos P, Orsi M (2021) Initial experience with teduglutide in pediatric intestinal failure. J Pediatr Gastroenterol Nutr 72:1284. https:\/\/doi.org\/10.1097\/MPG.0000000000003177","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7S2","key":"6474_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000575836.50667.7e","volume":"103","author":"SR Ferreiro","year":"2019","unstructured":"Ferreiro SR, Ruiz VC, Mart\u00ednez LG, Ramos RN, Recio JB, Canton S (2019) Teduglutide: the new weapon in pediatric short bowel syndrome. Transplantation 103(7S2):S74. https:\/\/doi.org\/10.1097\/01.tp.0000575836.50667.7e","journal-title":"Transplantation"},{"issue":"7S","key":"6474_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.tp.0000945780.96368.ee","volume":"107","author":"M Martinez","year":"2023","unstructured":"Martinez M, Rumbo C, Balacco M, Gondolesi G, Fernandez A (2023) Teduglutide therapy in children, six years of experience in a specialized Intestinal Rehabilitation Unit. Transplantation 107(7S):48. https:\/\/doi.org\/10.1097\/01.tp.0000945780.96368.ee","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"6474_CR29","doi-asserted-by":"publisher","first-page":"S1165","DOI":"10.1002\/jpr3.12073","volume":"5","author":"L Norsa","year":"2024","unstructured":"Norsa L, Ramos Boluda E, Lambe C, Guz Mark A, Hojsak I et al (2024) Predictors of response to glucagon-like peptide 2 in children with short bowel syndrome. JPGN Rep 5(Suppl 1):S1165\u2013S6. https:\/\/doi.org\/10.1002\/jpr3.12073","journal-title":"JPGN Rep"},{"key":"6474_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.tp.0000945784.79087.75","volume":"107","author":"L Merras-Salmio","year":"2023","unstructured":"Merras-Salmio L, Rikka G, Mutanen A, Pakarinen M (2023) 82: teduglutide in 19 pediatric SBS patients \u2013 single center real world data on clinical efficacy and treatment associated challenges. Transplantation 107:48\u201349. https:\/\/doi.org\/10.1097\/01.tp.0000945784.79087.75","journal-title":"Transplantation"},{"key":"6474_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jpn3.12276","volume":"79","author":"PW Wales","year":"2024","unstructured":"Wales PW et al (2024) Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure. J Pediatr Gastroenterol Nutr 79:290\u2013300. https:\/\/doi.org\/10.1002\/jpn3.12276","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl 1","key":"6474_CR32","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1002\/jpr3.12073","volume":"5","author":"C Rumbo","year":"2024","unstructured":"Rumbo C, Martinez M, Izquierdo C, Dlugoszewski C, Balacco M et al (2024) Real life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. JPGN Rep 5(Suppl 1):S206. https:\/\/doi.org\/10.1002\/jpr3.12073","journal-title":"JPGN Rep"},{"issue":"Suppl 1","key":"6474_CR33","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1002\/jpr3.12073","volume":"5","author":"A Molinaro","year":"2024","unstructured":"Molinaro A, Ramos Boluda E, Lambe C, Guz Mark A, Hozsak I et al (2024) Long-term teduglutide treatment in children with short bowel syndrome: A real-life, multicenter, retrospective study of patients treated for more than 1 year. JPGN Rep 5(Suppl 1):S52. https:\/\/doi.org\/10.1002\/jpr3.12073","journal-title":"JPGN Rep"},{"key":"6474_CR34","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1097\/01.tp.0000757952.00163.8c","volume":"105","author":"S Kinberg","year":"2021","unstructured":"Kinberg S, Haro C, Breza E, Park E, Berg E, Fallon E (2021) Single-center experience with teduglutide in pediatric patients with short bowel syndrome associated intestinal failure. Transplantation 105:S67\u2013S67. https:\/\/doi.org\/10.1097\/01.tp.0000757952.00163.8c","journal-title":"Transplantation"},{"key":"6474_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ncp.11209","volume":"40","author":"AM Nucci","year":"2025","unstructured":"Nucci AM, Bashaw H, Kirpich A, Rudolph J (2025) Retrospective review of growth in pediatric intestinal failure after weaning from parenteral nutrition. Nutr Clin Pract 40:176\u2013187. https:\/\/doi.org\/10.1002\/ncp.11209","journal-title":"Nutr Clin Pract"},{"issue":"6","key":"6474_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3760\/cma.j.cn115822-20240326-00058","volume":"32","author":"LN Lu","year":"2024","unstructured":"Lu LN, Feng HX, Huang LF et al (2024) Application of glucagon-like peptide-2 analogues in children with short bowel syndrome: a report of 2 cases. Chin J Clin Nutr 32(6):373\u2013377. https:\/\/doi.org\/10.3760\/cma.j.cn115822-20240326-00058","journal-title":"Chin J Clin Nutr"},{"key":"6474_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051238","volume":"13","author":"L Gombosova","year":"2024","unstructured":"Gombosova L, Suchansky M, Krivus J, Hornova J, Havlicekova Z, Fojtova A et al (2024) Evaluation of the effectiveness of teduglutide treatment in patients with short bowel syndrome in Slovakia-multicenter real-world study. J Clin Med 13:1238. https:\/\/doi.org\/10.3390\/jcm13051238","journal-title":"J Clin Med"},{"key":"6474_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1146\/annurev-physiol-021113-170317","volume":"76","author":"DJ Drucker","year":"2014","unstructured":"Drucker DJ, Yusta B (2014) Physiology and pharmacology of the entero endocrine hormone glucagon-like peptide-2. Annu Rev Physiol 76:561\u2013583. https:\/\/doi.org\/10.1146\/annurev-physiol-021113-170317","journal-title":"Annu Rev Physiol"},{"key":"6474_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/2050640617737632","volume":"6","author":"KC Fragkos","year":"2018","unstructured":"Fragkos KC, Forbes A (2018) Citrulline as a marker of intestinal function and absorption in clinical settings: A systematic review and meta-analysis. United Eur Gastroenterol J 6:181\u2013191. https:\/\/doi.org\/10.1177\/2050640617737632","journal-title":"United Eur Gastroenterol J"},{"key":"6474_CR40","unstructured":"Wang G (2024) Monthly report: new drug approvals in China, February 2024. BaiPharm. https:\/\/baipharm.chemlinked.com\/news\/monthly-report-new-drug-approvals-in-china-february-2024. Accessed 9 March 2025"},{"key":"6474_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/17474124.2021.1913052","volume":"15","author":"BE Rosete","year":"2021","unstructured":"Rosete BE, Wendel D, Horslen SP (2021) Teduglutide for pediatric short bowel syndrome patients. Expert Rev Gastroenterol Hepatol 15:727\u2013733. https:\/\/doi.org\/10.1080\/17474124.2021.1913052","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"6474_CR42","unstructured":"European Medicines Agency (2025) Revestive: EPAR \u2013 medicine overview. Amsterdam: EMA. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/revestive. Accessed 8 March 2025"},{"key":"6474_CR43","unstructured":"Pharmaceuticals and Medical Devices Agency (PMDA) (2025) Revestive subcutaneous injection 3.8\u00a0mg: Package Insert \/ Interview Form. Tokyo: PMDA. https:\/\/www.info.pmda.go.jp\/go\/interview\/1\/400256_2499419D1026_1_005_1F.pdf. Accessed 8 March 2025"},{"key":"6474_CR44","unstructured":"Hill S, Carter BA, Horslen S, Kocochis SA, Yoon M, Grimm A (2019) A prospective, open-label, long-term safety and efficacy study of teduglutide in paediatric patients with intestinal failure associated with short bowel syndrome: 6-month interim analysis (SHP633-303). Poster presented at the 52nd Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition; 5\u20138 June 2019, Glasgow, UK"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-026-06474-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-026-06474-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-026-06474-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:51:16Z","timestamp":1787219476000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-026-06474-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6474"],"URL":"https:\/\/doi.org\/10.1007\/s00383-026-06474-8","relation":{},"ISSN":["1437-9813"],"issn-type":[{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"WY and CW have received honoraria from Takeda for their roles as speakers and consultants. Takeda (China) International Trading Company provided support for the article\u2019s APC fee and sponsored the medical writing services.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"349"}}